AzTrials
AzTrials

Caregiver BurdenVRDCFIn-home1NCT07004842

Alternative Carer Respite: A Study on Its Effectiveness and Potential Mechanism

A study testing 48 hr Respite Service in people with Caregiver Burden, run by The University of Hong Kong at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this study is to examine the effectiveness of alternative carer respite in meeting the unique needs of older adults without children or with limited contact with their children in Hong Kong. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Caregiver Burden
What is being tested?
48 hr Respite Service
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteHong Kong
Study dates
1 Dec 2023to 30 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Either the CR or CG is aged ≥60
  • Reported having (a) no children; OR (b) no children in Hong Kong; OR (c) having children in Hong Kong but with limited contact (i.e., fewer than once per month in any forms)
  • Voluntary participation.

Who cannot join

  • Unable to communicate in neither Cantonese, English nor Mandarin

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • University of Hong Kong

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Alternative Carer Respite: A Study on Its Effectiveness and Potential Mechanisms

The primary objective of this study is to examine the effectiveness of alternative carer respite in meeting the unique needs of older adults without children or with limited contact with their children in Hong Kong. Caregivers are assessed before and after the intervention, and three months after the end of intervention on their physical health, mental well-being, social engagement, and overall satisfaction.

Read the detailed description

All participants will provide informed consent at the time of enrolment. Both caregivers and their care recipients will complete an assessment. Caregivers are screened for their physical health, mental well-being, social engagement, and overall satisfaction. Care recipients are screened using InterRAI for their physical functions.

Caregivers will receive a maximal of 48 hours of respite service within 6 month. Alternative caregivers will provide in-home elderly-sitting service so that the caregivers can have some private time for themselves.

At the end of the service period, caregivers and care recipients will complete the assessment again to measure the changes of their physical and mental health.

All participants will be contacted again for follow-up assessment 3 months after the completion of service.

Being tested
48 hr Respite Service
Keywords
respite, caregiver burden
Medical subject headings
Caregiver Burden

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 48 hr Respite ServiceOther

    Caregivers will be provided with 48 hours of respite service within 6 months. Trained alternative caregivers will provide elderly-sitting service at their home, allowing the caregivers to have their personal time.

Study groups in NCT07004842
Study groupRoleWhat they receive
CaregiversExperimentalCaregivers will receive 48 hours of respite service within 6 months
Receives: Other: 48 hr Respite Service

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in score in caregiving needs on the Carer Needs Screening Tool (CNST-11) after the intervention

    The Carer Needs Screening Tool (CNST-11) is a self-developed tool that measures different aspects of caregiving needs over the past 1 week period. It is a 11-item scale, with 8 items that determines the overall needs level and the others for four aspects of needs: physical health, mental health, social support and care needs. Possible score is from 8 to 32 with lower score indicates lower caregivers' needs.

    Change in score = Immediate after intervention - baseline

    Measured: Baseline and Immediate after intervention

  2. Change from baseline in score in depression symptoms on PHQ-9 after the intervention

    The Patient History Questionnaire (PHQ-9) is a widely used tool that consists of nine questions designed to screen and monitor the presence and severity of depression. The total score on the PHQ-9 ranges from 0 to 27, with higher scores indicating more severe depressive symptoms. The score ranges for the PHQ-9 are as follows: 0-4: Minimal depression symptoms; 5-9: Mild depression; 10-14: Moderate depression; 15-19: Moderately severe depression; 20-27: Severe depression Change in score = Immediate after intervention - baseline

    Measured: Baseline and Immediate after intervention

  3. Change from baseline in score in anxiety symptoms on GAD-7 after the intervention

    The Generalized Anxiety Disorder 7 (GAD-7) involves 7- items assessing the severity of anxiety symptoms. The total score on the GAD-7 ranges from 0 to 21, with higher scores indicating more severe anxiety symptoms. The score ranges for the GAD-7 are as follows: 0-4: Minimal anxiety symptoms; 5-9: Mild anxiety; 10-14: Moderate anxiety; 15-21: Severe anxiety.

    Change in score = Immediate after intervention - baseline

    Measured: Baseline and Immediate after intervention

  4. Change in score from baseline in quality of life measured by EQ-5D-5L after intervention

    The EQ-5D-5L is a standardized instrument used to assess health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The responses are converted into a single index value representing overall health status using Hong Kong's normative value. The primary outcome measure in this study is the change in EQ-5D-5L index scores from baseline to post-intervention/follow-up assessments. 1 equals to perfect health and more negative numbers indicates worse health. Change in health index = Immediate after intervention - baseline

    Measured: Baseline and Immediate after intervention

  5. Changes in score from baseline in perception of caregiving measured by Positive Aspect of Caregiving scale after intervention

    The Positive Aspect of Caregiving scale is a 11-item scale that measures how the caregiver perceive caregiving experience, specifically in a positive aspect (e.g., caregiving makes me feel useful). It is rated in a 5-point Likert scale from "very disagree" to "very agree", with potential score from 0 to 44. A higher score indicates caregiving perceiving it in a more positive way.

    Measured: Baseline and Immediate after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2025
  2. Study start1 Dec 2023
  3. Primary completion30 Nov 2025
  4. Study completion30 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07004842
Sponsor's protocol ID
EA230565
Acronym
VRDCFIn-home1
Status last verified
Apr 2026
First submitted
26 May 2025
Last updated
6 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: IPD (including protocol and anonymized dataset) will be made available upon request, subject to ethical review and data protection regulations

Questions about this trial

What is this clinical trial studying?

A study testing 48 hr Respite Service in people with Caregiver Burden, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in score in caregiving needs on the Carer Needs Screening Tool (CNST-11) after the intervention (time frame: Baseline and Immediate after intervention). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in